This announcement is a separate document:
カイオム・バイオサイエンス：Chiomeが抗CX3CR1抗体の独占ライセンス契約を発表
Chiome Bioscience: Chiome Announces Exclusive Licensing Agreement for Anti-CX3CR1 Antibody
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated